1. Home
  2. BNTC vs BRDG Comparison

BNTC vs BRDG Comparison

Compare BNTC & BRDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • BRDG
  • Stock Information
  • Founded
  • BNTC 1995
  • BRDG 2009
  • Country
  • BNTC United States
  • BRDG United States
  • Employees
  • BNTC N/A
  • BRDG N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • BRDG Investment Managers
  • Sector
  • BNTC Health Care
  • BRDG Finance
  • Exchange
  • BNTC Nasdaq
  • BRDG Nasdaq
  • Market Cap
  • BNTC 352.5M
  • BRDG 391.6M
  • IPO Year
  • BNTC N/A
  • BRDG 2021
  • Fundamental
  • Price
  • BNTC $13.63
  • BRDG $9.30
  • Analyst Decision
  • BNTC Strong Buy
  • BRDG Hold
  • Analyst Count
  • BNTC 7
  • BRDG 5
  • Target Price
  • BNTC $24.71
  • BRDG $11.00
  • AVG Volume (30 Days)
  • BNTC 34.2K
  • BRDG 191.3K
  • Earning Date
  • BNTC 05-16-2025
  • BRDG 05-20-2025
  • Dividend Yield
  • BNTC N/A
  • BRDG 4.95%
  • EPS Growth
  • BNTC N/A
  • BRDG N/A
  • EPS
  • BNTC N/A
  • BRDG 0.13
  • Revenue
  • BNTC N/A
  • BRDG $419,220,000.00
  • Revenue This Year
  • BNTC N/A
  • BRDG N/A
  • Revenue Next Year
  • BNTC N/A
  • BRDG $25.81
  • P/E Ratio
  • BNTC N/A
  • BRDG $71.34
  • Revenue Growth
  • BNTC N/A
  • BRDG 61.35
  • 52 Week Low
  • BNTC $5.74
  • BRDG $6.56
  • 52 Week High
  • BNTC $16.90
  • BRDG $11.69
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 49.98
  • BRDG 51.25
  • Support Level
  • BNTC $13.35
  • BRDG $9.01
  • Resistance Level
  • BNTC $15.69
  • BRDG $9.52
  • Average True Range (ATR)
  • BNTC 0.74
  • BRDG 0.29
  • MACD
  • BNTC -0.03
  • BRDG 0.01
  • Stochastic Oscillator
  • BNTC 20.46
  • BRDG 57.92

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About BRDG Bridge Investment Group Holdings Inc.

Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The Company operates as one business, a fully integrated real estate investment manager.

Share on Social Networks: